↓ Skip to main content

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Overview of attention for article published in Oncolytic Virotherapy, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

patent
9 patents

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Published in
Oncolytic Virotherapy, January 2016
DOI 10.2147/ov.s66083
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Austria 1 1%
Unknown 83 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 16 19%
Student > Ph. D. Student 15 18%
Student > Master 10 12%
Researcher 9 11%
Student > Doctoral Student 6 7%
Other 8 10%
Unknown 20 24%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 25 30%
Medicine and Dentistry 13 15%
Immunology and Microbiology 9 11%
Agricultural and Biological Sciences 8 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 6 7%
Unknown 21 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2025.
All research outputs
#4,699,124
of 31,634,113 outputs
Outputs from Oncolytic Virotherapy
#8
of 56 outputs
Outputs of similar age
#64,396
of 427,225 outputs
Outputs of similar age from Oncolytic Virotherapy
#1
of 1 outputs
Altmetric has tracked 31,634,113 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 56 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them